SupplyManager℠  Become a Customer

  • Hemocue #120706
  • 26
  • Item #462591
Point-of-Care Glucose Analyzer HemoCue® Glucose 201 1 Test CLIA Waived

Features
  • Hemocue glucose testing systems are based on a glucose dehydrogenase method and consist of a small dedicated analyzer and a unique disposable microcuvette
  • No calibration or microcuvette batch-to-batch variations
  • Glucose 201 analyzer: 0-444 mg/dl (0-24.6 mmol/l)
  • Lab-accurate results
  • Only 5 µL of capillary, venous, or arterial blood is needed
  • More …
Log In for Pricing and Availability
or
Become a Customer

Product Specifications


McKesson #462591
Manufacturer #120706
BrandHemoCue® Glucose 201
ManufacturerHemocue
ApplicationPoint-of-Care Glucose Analyzer
CLIA ClassificationCLIA Waived
Dimensions3.35 X 6.30 X 1.69 Inch
For Use WithHemoCue® Glucose 201 Microcuvette
Number of Tests1 Test
Readout TypeDigital Display
Sample TypeCapillary / Venous / Aterial Whole Blood Sample
Test NameBlood Glucose Level
Test Time4 Minute Results
UNSPSC Code41116201
Weight0.77 lbs.
Features
  • Hemocue glucose testing systems are based on a glucose dehydrogenase method and consist of a small dedicated analyzer and a unique disposable microcuvette
  • No calibration or microcuvette batch-to-batch variations
  • Glucose 201 analyzer: 0-444 mg/dl (0-24.6 mmol/l)
  • Lab-accurate results
  • Only 5 µL of capillary, venous, or arterial blood is needed
  • Following the three simple steps, the hemocue glucose systems will produce lab-accurate results for diagnosing or monitoring diabetes, as well as monitoring neonatal blood glucose levels